Advertisement

The Importance of Diversity in Clinical Trials for Hepatitis C

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.

Featured Content

video

My Story: My Hepatitis C Journey as a Black American

Pat, a hepatitis c survivor, shares her thoughts on disparity within the healthcare system.
article

Why Hepatitis C is Called a "Quiet Killer"

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.
video

6 Things Hep C Patients Need When Calling an Insurance Company

Having this important information at your fingertips will streamline the process and save you some time.
article

Steps to Diagnosing and Getting Treatment for Hep C

What to expect during and after hep C screening and how to decide on a treatment plan.
video

How Blood Transfusions for Sickle Cell May Have Impacted Hepatitis C Rates Among Black Americans

In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.